{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:38:11Z","timestamp":1792802291481,"version":"4.5.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Dubin-Johnson syndrome (DJS) results from ABCC2\/MRP2 mutations causing impaired biliary transport. MRP2 also mediates hepatic elimination of chemotherapeutic agents, yet no data exist on anthracycline-based chemotherapy in adult DJS patients. We report a 26-year-old male with advanced-stage classic Hodgkin lymphoma and DJS harboring a novel homozygous ABCC2 variant (c.2291G&gt;A, p.Gly764Asp). After a pembrolizumab prephase, full-dose BrECADD was administered, and samples were taken for therapeutic drug monitoring (TDM), which demonstrated normal etoposide and doxorubicin pharmacokinetics. Complete metabolic remission was achieved without significant toxicity. This case demonstrates that TDM-guided, full-dose anthracycline-based chemotherapy is feasible in DJS.<\/jats:p>","DOI":"10.1007\/s00280-026-04975-w","type":"journal-article","created":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:34:11Z","timestamp":1792740851000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Successful treatment with BrECADD in a patient with Dubin-Johnson syndrome and classic Hodgkin lymphoma: a case report"],"prefix":"10.1007","volume":"96","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-5680-8714","authenticated-orcid":false,"given":"Hishan","family":"Tharmaseelan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian Peter","family":"Jaworek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Borchmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conrad-Amadeus","family":"Voltin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Galler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gareth J.","family":"Veal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louisa","family":"Lepkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Reusch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Velmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Netzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Fuhr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelby","family":"Barnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,23]]},"reference":[{"key":"4975_CR1","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/hep.510250635","volume":"25","author":"CC Paulusma","year":"1997","unstructured":"Paulusma CC et al (1997) A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome. Hepatology 25:1539\u20131542","journal-title":"Hepatology"},{"key":"4975_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/B978-1-4377-0881-3.00004-8","volume-title":"Zakim and Boyer\u2019s Hepatology (Sixth Edition)","author":"PLM Jansen","year":"2012","unstructured":"Jansen PLM, Beuers U, Elferink RPJO (2012) Chapter 4 - Mechanisms of Bile Secretion. In: Boyer TD, Manns MP, Sanyal AJ (eds) Zakim and Boyer\u2019s Hepatology (Sixth Edition). W.B. Saunders, Saint Louis, pp 47\u201363. doi:https:\/\/doi.org\/10.1016\/B978-1-4377-0881-3.00004-8."},{"key":"4975_CR3","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/ijc.10246","volume":"98","author":"Y Tada","year":"2002","unstructured":"Tada Y et al (2002) Increased expression of multidrug resistance-associated proteins in bladder cancer during clinical course and drug resistance to doxorubicin. Int J Cancer 98:630\u2013635","journal-title":"Int J Cancer"},{"key":"4975_CR4","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s00280-023-04565-0","volume":"92","author":"S Barnett","year":"2023","unstructured":"Barnett S et al (2023) Excessive vincristine exposure in a child being treated for acute lymphoblastic leukaemia with underlying Dubin\u2013Johnson syndrome: a case report. Cancer Chemother Pharmacol 92:325\u2013328","journal-title":"Cancer Chemother Pharmacol"},{"key":"4975_CR5","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1080\/02841860701644078","volume":"47","author":"A Ballonoff","year":"2008","unstructured":"Ballonoff A et al (2008) Hodgkin lymphoma-related vanishing bile duct syndrome and idiopathic cholestasis: Statistical analysis of all published cases and literature review. Acta Oncol 47:962\u2013970","journal-title":"Acta Oncol"},{"key":"4975_CR6","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405\u2013424","journal-title":"Genet Med"},{"key":"4975_CR7","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0140-6736(24)01315-1","volume":"404","author":"P Borchmann","year":"2024","unstructured":"Borchmann P et al (2024) Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21): a randomised, multicentre, parallel, open-label, phase 3 trial. Lancet 404:341\u2013352","journal-title":"Lancet"},{"key":"4975_CR8","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/S0026-895X(24)23190-4","volume":"55","author":"Y Cui","year":"1999","unstructured":"Cui Y et al (1999) Drug Resistance and ATP-Dependent Conjugate Transport Mediated by the Apical Multidrug Resistance Protein, MRP2, Permanently Expressed in Human and Canine Cells. Mol Pharmacol 55:929\u2013937","journal-title":"Mol Pharmacol"},{"key":"4975_CR9","doi-asserted-by":"publisher","first-page":"S76","DOI":"10.1007\/BF00684868","volume":"34","author":"CF Stewart","year":"1994","unstructured":"Stewart CF (1994) Use of etoposide in patients with organ dysfunction: pharmacokinetic and pharmacodynamic considerations. Cancer Chemother Pharmacol 34:S76\u2013S83","journal-title":"Cancer Chemother Pharmacol"},{"key":"4975_CR10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2165\/00003088-198815010-00002","volume":"15","author":"PAJ Speth","year":"1988","unstructured":"Speth PAJ, Van Hoesel QGCM, Haanen C (1988) Clinical Pharmacokinetics of Doxorubicin. Clin Pharmacokinet 15:15\u201331","journal-title":"Clin Pharmacokinet"},{"key":"4975_CR11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/liv.14260","volume":"40","author":"C Corpechot","year":"2020","unstructured":"Corpechot C et al (2020) Genetic contribution of ABCC2 to Dubin-Johnson syndrome and inherited cholestatic disorders. Liver Int 40:163\u2013174","journal-title":"Liver Int"},{"key":"4975_CR12","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.lungcan.2008.03.008","volume":"62","author":"B You","year":"2008","unstructured":"You B et al (2008) Etoposide pharmacokinetics and survival in patients with small cell lung cancer: A multicentre study. Lung Cancer 62:261\u2013272","journal-title":"Lung Cancer"},{"key":"4975_CR13","doi-asserted-by":"publisher","first-page":"223","DOI":"10.2165\/00003088-198712040-00001","volume":"12","author":"PI Clark","year":"1987","unstructured":"Clark PI, Slevin ML (1987) The Clinical Pharmacology of Etoposide and Teniposide. Clin Pharmacokinet 12:223\u2013252","journal-title":"Clin Pharmacokinet"},{"key":"4975_CR14","doi-asserted-by":"publisher","unstructured":"Hall RG et al (2025) Impact of obesity on doxorubicin pharmacokinetics in women with breast cancer. J Oncol Pharm Pract 10781552251326045. https:\/\/doi.org\/10.1177\/10781552251326045","DOI":"10.1177\/10781552251326045"},{"key":"4975_CR15","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s00280-013-2069-1","volume":"71","author":"NE Kontny","year":"2013","unstructured":"Kontny NE et al (2013) Population pharmacokinetics of doxorubicin: establishment of a NONMEM model for adults and children older than 3 years. Cancer Chemother Pharmacol 71:749\u2013763","journal-title":"Cancer Chemother Pharmacol"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-026-04975-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00280-026-04975-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-026-04975-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:03:20Z","timestamp":1792800200000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00280-026-04975-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,23]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4975"],"URL":"https:\/\/doi.org\/10.1007\/s00280-026-04975-w","relation":{},"ISSN":["1432-0843"],"issn-type":[{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,23]]},"assertion":[{"value":"29 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"123"}}